These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 33207023)
61. Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol. Inoue T; Sugiyama T; Matsubara T; Kawai S; Furukawa S Endocr J; 2001 Feb; 48(1):11-8. PubMed ID: 11403096 [TBL] [Abstract][Full Text] [Related]
62. Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia. Voskaridou E; Terpos E; Spina G; Palermos J; Rahemtulla A; Loutradi A; Loukopoulos D Br J Haematol; 2003 Nov; 123(4):730-7. PubMed ID: 14616979 [TBL] [Abstract][Full Text] [Related]
63. A change of osteocalcin (OC) and tartrate resistant acid phosphatase 5b (TRACP-5b) with the menstrual cycle. Lee S; Kumagai T; Hashimoto J; Satoh A; Suzuki T; Yamai K; Ohta S Horm Metab Res; 2012 Sep; 44(9):699-703. PubMed ID: 22517558 [TBL] [Abstract][Full Text] [Related]
64. The impact of subcutaneous oestradiol implants on biochemical markers of bone turnover and bone mineral density in postmenopausal women. Pereda CA; Hannon RA; Naylor KE; Eastell R BJOG; 2002 Jul; 109(7):812-20. PubMed ID: 12135219 [TBL] [Abstract][Full Text] [Related]
65. Correlation of undercarboxylated osteocalcin (ucOC) concentration and bone density with age in healthy Korean women. Kim SM; Kim KM; Kim BT; Joo NS; Kim KN; Lee DJ J Korean Med Sci; 2010 Aug; 25(8):1171-5. PubMed ID: 20676328 [TBL] [Abstract][Full Text] [Related]
66. Does methamphetamine affect bone metabolism? Tomita M; Katsuyama H; Watanabe Y; Okuyama T; Fushimi S; Ishikawa T; Nata M; Miyamoto O Toxicology; 2014 May; 319():63-8. PubMed ID: 24582730 [TBL] [Abstract][Full Text] [Related]
67. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer. Ozu C; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459 [TBL] [Abstract][Full Text] [Related]
68. Changes in bone mass and bone turnover following ankle fracture. Ingle BM; Hay SM; Bottjer HM; Eastell R Osteoporos Int; 1999; 10(5):408-15. PubMed ID: 10591839 [TBL] [Abstract][Full Text] [Related]
69. Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease. Morisawa T; Nakagomi A; Kohashi K; Kusama Y; Shimizu W J Atheroscler Thromb; 2017 Oct; 24(10):1058-1068. PubMed ID: 28428481 [TBL] [Abstract][Full Text] [Related]
70. Ibandronate treatment reverses glucocorticoid-induced loss of bone mineral density and strength in minipigs. Glüer CC; Scholz-Ahrens KE; Helfenstein A; Delling G; Timm W; Açil Y; Barkmann R; Hassenpflug J; Stampa B; Bauss F; Schrezenmeir J Bone; 2007 Mar; 40(3):645-55. PubMed ID: 17174621 [TBL] [Abstract][Full Text] [Related]
71. Changes in bone mass and bone turnover following distal forearm fracture. Ingle BM; Hay SM; Bottjer HM; Eastell R Osteoporos Int; 1999; 10(5):399-407. PubMed ID: 10591838 [TBL] [Abstract][Full Text] [Related]
72. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children. Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534 [TBL] [Abstract][Full Text] [Related]
73. Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover. Indridason OS; Franzson L; Sigurdsson G Osteoporos Int; 2005 Apr; 16(4):417-23. PubMed ID: 15776220 [TBL] [Abstract][Full Text] [Related]
74. The effect of denosumab in breast cancer patients receiving adjuvant aromatase inhibitors: 36-month results. Ouchi Y; Nakatsukasa K; Sakaguchi K; Morita M; Koyama H; Matsuda T; Kato M; Konishi E; Ono H; Taguchi T J Bone Miner Metab; 2021 Mar; 39(2):224-229. PubMed ID: 32889575 [TBL] [Abstract][Full Text] [Related]
75. Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin. Janckila AJ; Simons RM; Yam LT Clin Chim Acta; 2004 Sep; 347(1-2):157-67. PubMed ID: 15313154 [TBL] [Abstract][Full Text] [Related]
76. A dried blood spot-based method to measure levels of tartrate-resistant acid phosphatase 5b (TRACP-5b), a marker of bone resorption. Eick GN; Devlin MJ; Cepon-Robins TJ; Kowal P; Sugiyama LS; Snodgrass JJ Am J Hum Biol; 2019 May; 31(3):e23240. PubMed ID: 30897260 [TBL] [Abstract][Full Text] [Related]
78. Congenital Hypothyroidism and Bone Remodeling Cycle. Karakaş NM; Tulgar Kınık S; Özdemir B; Muratoğlu Şahin N; Tekindal MA; Haberal A J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):106-110. PubMed ID: 27840329 [TBL] [Abstract][Full Text] [Related]
79. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption. Aonuma H; Miyakoshi N; Hongo M; Kasukawa Y; Shimada Y Tohoku J Exp Med; 2009 Jul; 218(3):201-5. PubMed ID: 19561390 [TBL] [Abstract][Full Text] [Related]
80. Seasonal Variations of Bone Metabolism and Bone Mineral Density in Collegiate Alpine Skiers. Sato T; Sakuraba K; Tsuchiya Y; Maruyama S; Ochi E J Strength Cond Res; 2018 May; 32(5):1448-1454. PubMed ID: 28486336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]